Yufan C. Ying
Qingchun Road 79
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
piR-43452 suppresses bladder cancer progression and enhances gemcitabine sensitivity via GTSF1/PIWIL4-mediated LRP1 mRNA destabilization.
Journal: Translational oncology
Published: October 03, 2025
SREBF1-mediated SND1 transcriptional activation promotes prostate cancer progression via MTDH interaction through the SESN2/AMPK/mTOR axis.
Journal: Journal of translational medicine
Published: February 11, 2025
The role and clinical potential of RNA modifications in bladder cancer.
Journal: Bladder (San Francisco, Calif.)
Published: November 14, 2024
Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study.
Journal: World journal of surgical oncology
Published: September 25, 2024
Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer.
Journal: Molecular cancer
Published: November 16, 2023
Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer
Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: August 11, 2022
Diverse Roles and Therapeutic Potentials of Circular RNAs in Urological Cancers.
Journal: Frontiers in molecular biosciences
Published: August 20, 2021
Last Updated: 09/26/2026